Literature DB >> 33608508

Zinc transporter ZIP7 is a novel determinant of ferroptosis.

Po-Han Chen1,2, Jianli Wu1,2, Yitong Xu1,2, Chien-Kuang Cornelia Ding1,2, Alexander A Mestre1,2,3, Chao-Chieh Lin1,2, Wen-Hsuan Yang1,2,3, Jen-Tsan Chi4,5.   

Abstract

Ferroptosis is a newly described form of regulated cell death triggered by oxidative stresses and characterized by extensive lipid peroxidation and membrane damages. The name of ferroptosis indicates that the ferroptotic death process depends on iron, but not other metals, as one of its canonical features. Here, we reported that zinc is also essential for ferroptosis in breast and renal cancer cells. Zinc chelator suppressed ferroptosis, and zinc addition promoted ferroptosis, even during iron chelation. By interrogating zinc-related genes in a genome-wide RNAi screen of ferroptosis, we identified SLC39A7, encoding ZIP7 that controls zinc transport from endoplasmic reticulum (ER) to cytosol, as a novel genetic determinant of ferroptosis. Genetic and chemical inhibition of the ZIP7 protected cells against ferroptosis, and the ferroptosis protection upon ZIP7 knockdown can be abolished by zinc supplementation. We found that the genetic and chemical inhibition of ZIP7 triggered ER stresses, including the induction of the expression of HERPUD1 and ATF3. Importantly, the knockdown of HERPUD1 abolished the ferroptosis protection phenotypes of ZIP7 inhibition. Together, we have uncovered an unexpected role of ZIP7 in ferroptosis by maintaining ER homeostasis. These findings may have therapeutic implications for human diseases involving ferroptosis and zinc dysregulations.

Entities:  

Year:  2021        PMID: 33608508      PMCID: PMC7895949          DOI: 10.1038/s41419-021-03482-5

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  57 in total

1.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.

Authors:  Sonam Dolma; Stephen L Lessnick; William C Hahn; Brent R Stockwell
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

2.  Zinc deficiency: changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and in noncancer subjects.

Authors:  A S Prasad; F W Beck; S M Grabowski; J Kaplan; R H Mathog
Journal:  Proc Assoc Am Physicians       Date:  1997-01

3.  Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11.

Authors:  Xueting Lang; Michael D Green; Weimin Wang; Jiali Yu; Jae Eun Choi; Long Jiang; Peng Liao; Jiajia Zhou; Qiang Zhang; Ania Dow; Anjali L Saripalli; Ilona Kryczek; Shuang Wei; Wojciech Szeliga; Linda Vatan; Everett M Stone; George Georgiou; Marcin Cieslik; Daniel R Wahl; Meredith A Morgan; Arul M Chinnaiyan; Theodore S Lawrence; Weiping Zou
Journal:  Cancer Discov       Date:  2019-09-25       Impact factor: 39.397

4.  Synchronized renal tubular cell death involves ferroptosis.

Authors:  Andreas Linkermann; Rachid Skouta; Nina Himmerkus; Shrikant R Mulay; Christin Dewitz; Federica De Zen; Agnes Prokai; Gabriele Zuchtriegel; Fritz Krombach; Patrick-Simon Welz; Ricardo Weinlich; Tom Vanden Berghe; Peter Vandenabeele; Manolis Pasparakis; Markus Bleich; Joel M Weinberg; Christoph A Reichel; Jan Hinrich Bräsen; Ulrich Kunzendorf; Hans-Joachim Anders; Brent R Stockwell; Douglas R Green; Stefan Krautwald
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

5.  The Zinc Transporter SLC39A7 (ZIP7) Is Essential for Regulation of Cytosolic Zinc Levels.

Authors:  Grace Woodruff; Christian G Bouwkamp; Femke M de Vrij; Timothy Lovenberg; Pascal Bonaventure; Steven A Kushner; Anthony W Harrington
Journal:  Mol Pharmacol       Date:  2018-07-06       Impact factor: 4.436

Review 6.  Current understanding of ZIP and ZnT zinc transporters in human health and diseases.

Authors:  Taiho Kambe; Ayako Hashimoto; Shigeyuki Fujimoto
Journal:  Cell Mol Life Sci       Date:  2014-04-08       Impact factor: 9.261

7.  Increased erythrophagocytosis induces ferroptosis in red pulp macrophages in a mouse model of transfusion.

Authors:  Lyla A Youssef; Abdelhadi Rebbaa; Sergey Pampou; Stuart P Weisberg; Brent R Stockwell; Eldad A Hod; Steven L Spitalnik
Journal:  Blood       Date:  2018-04-17       Impact factor: 22.113

Review 8.  Zinc homeostasis and signaling in health and diseases: Zinc signaling.

Authors:  Toshiyuki Fukada; Satoru Yamasaki; Keigo Nishida; Masaaki Murakami; Toshio Hirano
Journal:  J Biol Inorg Chem       Date:  2011-06-10       Impact factor: 3.358

9.  Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation.

Authors:  M Hayano; W S Yang; C K Corn; N C Pagano; B R Stockwell
Journal:  Cell Death Differ       Date:  2015-07-17       Impact factor: 15.828

10.  Unsolved mysteries: How does lipid peroxidation cause ferroptosis?

Authors:  Huizhong Feng; Brent R Stockwell
Journal:  PLoS Biol       Date:  2018-05-24       Impact factor: 8.029

View more
  14 in total

Review 1.  Organelle-specific regulation of ferroptosis.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 12.067

Review 2.  Ferroptosis as a mechanism of non-ferrous metal toxicity.

Authors:  Michael Aschner; Alexey A Tinkov; Anatoly V Skalny; Airton C Martins; Anton I Sinitskii; Marcelo Farina; Rongzhu Lu; Fernando Barbosa; Yordanka G Gluhcheva; Abel Santamaria
Journal:  Arch Toxicol       Date:  2022-06-21       Impact factor: 6.168

Review 3.  The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis.

Authors:  Yixuan Zhang; Mingrui Li; Yiming Guo; Shuang Liu; Yongguang Tao
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

4.  The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2.

Authors:  Wen-Hsuan Yang; Chao-Chieh Lin; Jianli Wu; Pei-Ya Chao; Kuan Chen; Po-Han Chen; Jen-Tsan Chi
Journal:  Mol Cancer Res       Date:  2021-03-11       Impact factor: 5.852

5.  The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer.

Authors:  Jen-Tsan Chi; Pao-Hwa Lin; Vladimir Tolstikov; Taofik Oyekunle; Gloria C G Alvarado; Adela Ramirez-Torres; Emily Y Chen; Valerie Bussberg; Bo Chi; Bennett Greenwood; Rangaprasad Sarangarajan; Niven R Narain; Michael A Kiebish; Stephen J Freedland
Journal:  Prostate       Date:  2021-05-05       Impact factor: 4.012

6.  Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial.

Authors:  Jen-Tsan Chi; Pao-Hwa Lin; Vladimir Tolstikov; Lauren Howard; Emily Y Chen; Valerie Bussberg; Bennett Greenwood; Niven R Narain; Michael A Kiebish; Stephen J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-03-25       Impact factor: 5.455

7.  Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.

Authors:  Jing Zhou; Xinyue Wang; Zhaona Li; Richeng Jiang
Journal:  FEBS Open Bio       Date:  2021-10-16       Impact factor: 2.693

8.  Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with Ferroptosis.

Authors:  Jing-Xiao Li; Jin-Shu Pang; Bin-Tong Yin; Gang Chen; Jun-Hong Chen; Jia-Yuan Luo; Xia Yang; Li-Ting Qin; Jiang-Hui Zeng; Peng Chen; Jia-Bo Chen; Deng Tang
Journal:  Int J Gen Med       Date:  2021-12-06

Review 9.  Cell Death via Lipid Peroxidation and Protein Aggregation Diseases.

Authors:  Katsuya Iuchi; Tomoka Takai; Hisashi Hisatomi
Journal:  Biology (Basel)       Date:  2021-05-04

10.  The regulation of ferroptosis by MESH1 through the activation of the integrative stress response.

Authors:  Chao-Chieh Lin; Chien-Kuang Cornelia Ding; Tianai Sun; Jianli Wu; Kai-Yuan Chen; Pei Zhou; Jen-Tsan Chi
Journal:  Cell Death Dis       Date:  2021-07-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.